Frequently Asked Questions
- What is Cardiome’s Business?
- What exchange is Cardiome traded on, and what is the symbol?
- When are Cardiome’s fiscal quarter and year-end dates, and what are the corresponding dates for release of results?
- Who is Cardiome’s Transfer Agent?
- How can I access Cardiome's regulatory filings?
- When is Cardiome's Annual General Meeting?
- What is Cardiome's Code of Conduct?
What is Cardiome’s Business?
Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.
What exchange is Cardiome traded on, and what is the symbol?
Cardiome is traded on the Nasdaq Global Market under the symbol "CRME" and the Toronto Stock Exchange under the symbol "COM".
When are Cardiome’s fiscal quarter and year-end dates, and what are the corresponding dates for release of results?
As of 2003, Cardiome operates on a fiscal year ending December 31; previously the year end was November 30. Our quarterly reporting periods are March 31, June 30, September 30 and December 31. Quarterly results are issued approximately 6 weeks after the end of the reporting period.
Who is Cardiome’s Transfer Agent?
Communication concerning transfer requirements, lost certificates, change of address and other similar inquiries should be addressed to our transfer agent:
Computershare Trust Company of Canada
510 Burrard Street, 2nd Floor
Vancouver, B.C. V6C 3B9
Telephone: 604-661-9400
Fax: 604-661-9549
Where can I access Cardiome’s regulatory filings?
Our Canadian filings are available on SEDAR at www.sedar.com and our U.S. filings are available on EDGAR.
When is Cardiome's Annual General Meeting?
Our Annual General Meeting was held on June 15th, 2009 at 1:30pm in the 2nd Floor Boardroom at 6190 Agronomy Road, Vancouver, British Columbia. Our 2010 AGM is not yet scheduled.
What is Cardiome's Code of Conduct?
Cardiome’s Code of Conduct can be accessed here